Announced Thu, 6 Nov · 14:57 IST

Link Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Unaudited Financial Results ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Link Pharma Chem Ltd has informed BSE that its Board of Directors will meet on 13th November 2025 to consider and approve the unaudited financial results for the quarter and half year ended 30th September 2025. The filing is made under SEBI Listing Regulations. The trading window for designated persons has been closed since 1st October 2025 and will reopen 48 hours after the results are declared. No financial figures or material decisions have been disclosed in this intimation.

Likely market impact

This is a routine procedural filing ahead of the Q2 earnings announcement. Shareholders should wait for the actual results on 13th November for any meaningful insight into the company's performance; the stock may see limited activity until then due to the closed trading window.